SEARCH

SEARCH BY CITATION

References

  • Aldinucci, D., Poletto, D., Nanni, P., Degan, M., Rupolo, M., Pinto, A. & Gattei, V. (2002) CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts. Experimental Hematology, 30, 12831292.
  • Armitage, P. & Berry, G. (1987) Statistical Methods in Medical Research. Blackwell Scientific, London, UK.
  • Baum, C.M., Weissman, I.L., Tsukamoto, A.S., Buckle, A.M. & Peault, B. (1992) Isolation of a candidate human hematopoietic stem-cell population. Proceedings of the National Academy of Sciences of the United States of America, 89, 28042808.
  • Bennet, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) The French–American–British (FAB) co-operative group. Proposal for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189199.
  • Blair, A., Hogge, D.E., Ailles, L.E., Lansdorp, P.M. & Sutherland, H.J. (1997) Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood, 89, 31043111.
  • Bloomfield, C.D., Lawrence, D., Byrd, J.C., Carroll, A., Pettenati, M.J., Tantravahi, R., Patil, S.R., Davey, F.R., Berg, D.T., Schiffer, C.A., Arthur, D.C. & Mayer, R.J. (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Research, 58, 41734179.
  • Brendel, C., Mohr, B., Schimmelpfennig, C., Muller, J., Bornhauser, M., Schmidt, M., Ritter, M., Ehninger, G. & Neubauer, A. (1999) Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias. Leukemia, 13, 17701775.
  • Campos, L. & Guyotat, D. (1996) Expression of Thy-1 antigen (CDw90) on adult acute leukemia blast cells (letter). Blood, 87, 413414.
  • Craig, W., Kay, R., Cutler, R.L. & Lansdorp, P.M. (1993) Expression of Thy-1 on human hematopoietic progenitor cells. Journal of Experimental Medicine, 177, 13311342.
  • Degan, M., Mazzocco, F.T., Di Francia, R., Rossi, F.M., Pinto, A. & Gattei, V. (2000) Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia. Diagnostic and Molecular Pathology, 9, 98109.
  • Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S. & Papa, G. (1996) Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood, 87, 19972004.
  • Del Poeta, G., Venditti, A., Stasi, R., Aronica, G., Cox, M.C., Buccisano, F., Tamburini, A., Bruno, A., Maurillo, L., Battaglia, A., Suppo, G., Epiceno, A.M., Del Moro, B., Masi, M., Amadori, S. & Papa, G. (1999) P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia. Leukemia Research, 23, 451465.
  • Del Poeta, G., Venditti, A., Del Principe, M.I., Maurillo, L., Buccisano, F., Tamburini, A., Cox, M.C., Franchi, A., Bruno, A., Mazzone, C., Panetta, P., Suppo, G., Masi, M. & Amadori, S. (2003) Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood, 101, 21252131.
  • DePinho, R.A. (2000) The age of cancer. Nature, 408, 248254.
  • Fialkow, P.J., Raskind, W.R., Singer, J.W., Dow, L.W., Najfeld, V. & Veith, R. (1989) Clonal development of the acute leukemias. Bone Marrow Transplantation, 4(Suppl. 1), 7678.
  • Fialkow, P.J., Janssen, J.W. & Bartram, C.R. (1991) Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy. Blood, 77, 14151417.
  • Gattei, V., Aldinucci, D., Quinn, J.M., Degan, M., Cozzi, M., Perin, V., Iuliis, A.D., Juzbasic, S., Improta, S., Athanasou, N.A., Ashman, L.K. & Pinto, A. (1996) Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor. Cell Growth and Differentiation, 7, 753763.
  • Gattei, V., Degan, M., Gloghini, A., De Iuliis, A., Improta, S., Rossi, F.M., Aldinucci, D., Perin, V., Serraino, D., Babare, R., Zagonel, V., Gruss, H.J., Carbone, A. & Pinto, A. (1997) CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood, 89, 20482059.
  • Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. & Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 92, 23222333.
  • Haase, D., Feuring-Buske, M., Schafer, C., Schafer, C., Schoch, C., Troff, C., Gahn, B., Hiddemann, W. & Wormann, B. (1997) Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Leukemia, 5, 674679.
  • Hann, I.M., Stevens, R.F., Goldstone, A.H., Rees, J.K., Wheatley, K., Gray, R.G. & Burnett, A.K. (1997) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood, 89, 23112318.
  • Head, D.R. (1996) Revised classification of acute myeloid leukemia. Leukemia, 10, 18261831.
  • Heaney, M.L. & Golde, D.W. (1999) Myelodysplasia. New England Journal of Medicine, 340, 16491660.
  • Holden, J.T., Geller, R.B., Farhi, D.C., Holland, H.K., Stempora, L.L., Phillips, C.N. & Bray, R.A. (1995) Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia. Blood, 86, 6065.
  • Humeau, L., Bardin, F., Maroc, C., Alario, T., Galindo, R., Mannoni, P. & Chabannon, C. (1996) Phenotypic, molecular, and functional characterization of human peripheral blood CD34+/THY1+ cells. Blood, 87, 949955.
  • Inaba, T., Shimazaki, C., Sumikuma, T., Takahashi, R., Hirai, H., Kikuta, T., Sudo, Y., Yamagata, N., Ashihara, E., Goto, H., Fujita, N., Yoshimura, M. & Nakagawa, M. (1997) Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia. International Journal of Hematology, 66, 315323.
  • Inaba, T., Shimazaki, C., Sumikuma, T., Shimura, K., Takahashi, R., Hirai, H., Ashihara, E., Sudo, Y., Murakami, S., Haruyama, H., Fujita, N., Yoshimura, M. & Nakagawa, M. (1998) Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome. Internal Journal of Hematology, 68, 403410.
  • Johansson, B., Mertens, F. & Mitelman, F. (1996) Primary vs. secondary neoplasia-associated chromosomal abnormalities-balanced rearrangements vs. genomic imbalances? Genes, Chromosomes and Cancer, 16, 155163.
  • Kaplan, E.L. & Meier, P. (1958) Non parametric estimations from incomplete observations. Journal of American Statistical Association, 53, 457461.
  • Kozii, R., Wilson, J., Persichetti, J., Phelps, V., Ball, S.E. & Ball, E.D. (1997) Thy-1 expression on blast cells from adult patients with acute myeloid leukemia. Leukemia Research, 21, 381385.
  • Lansdorp, P.M., Sutherland, H.J. & Eaves, C.J. (1990) Selective expression of CD45 isoforms on functional subpopulations of CD34+ haemopoietic cells from human bone marrow. Journal of Experimental Medicine, 172, 363366.
  • Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.M., Head, D.R., Appelbaum, F.R. & Willman, C.L. (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood, 89, 33233329.
  • Low, M.G. & Kincade, P.W. (1985) Phosphatydilinositol is the membrane anchoring domain of the Thy-1 glycoprotein. Nature, 318, 6264.
  • Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & Lo Coco, F. (1997) Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood, 90, 10141021.
  • Masuya, M., Kita, K., Shimizu, N., Ohishi, K., Katayama, N., Sekine, T., Otsuji, A., Miwa, H. & Shirakawa, S. (1993) Biologic characteristics of acute leukemia after myelodysplastic syndrome. Blood, 81, 33883394.
  • Mauritzson, N., Johansson, B., Albin, M., Billstrom, R., Ahlgren, T., Mikoczy, Z., Nilsson, P.G., Hagmar, L. & Mitelman, F. (1999) A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. European Journal of Haematology, 62, 95102.
  • Mayani, H. & Lansdorp, P.M. (1994) Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood, 99, 19091912.
  • Mitelman, F. (ed.) (1995) ISCN: An International System for Human Cytogenetic Nomenclature. Karger, Basel, Switzerland.
  • Moorman, A.V., Roman, E., Willett, E.V., Dovey, G.J., Cartwright, R.A. & Morgan, G.J. (2001) Karyotype and age in acute myeloid leukemia. Are they linked? Cancer Genetics and Cytogenetics, 126, 155161.
  • Mrozek, K., Heinonen, K. & Bloomfield, C.D. (2000) Prognostic value of cytogenetic findings in adults with acute myeloid leukemia. Internal Journal of Hematology, 72, 261271.
  • Nilsson, L., Astrand-Grundstrom, I., Arvidsson, I., Jacobsson, B., Hellström-Lindberg, E., Hast, R. & Jacobsen, S.E.W. (2000) Isolation an characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes. Evidence for involvement at the hematopoietic stem cell level. Blood, 96, 20122021.
  • Nilsson, L., Åstrand-Grundström, I., Anderson, K., Arvidsson, I., Hokland, P., Bryder, D., Kjeldsen, L., Johansson, B., Hellström-Lindberg, E., Hast, R. & Jacobsen, S.E.W. (2002) Involvement and functional impairment of the CD34+ CD38 Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood, 100, 259267.
  • Pedersen-Bjergaard, J., Andersen, M.K., Christiansen, D.H. & Nerlov, C. (2002) Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood, 99, 19091912.
  • Pinto, A., Aldinucci, D., Gattei, V., Zagonel, V., Tortora, G., Budillon, A. & Cho-Chung, Y.S. (1992) Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate. Proceedings of the National Academy of Sciences of the United States of America, 89, 88848888.
  • Rosenfeld, C. & Kantarjian, H. (2001) Is myelodysplastic related acute myelogenous leukemia a distinct entity from de novo acute myelogenous leukemia? Potential for targeted therapies. Leukemia & Lymphoma, 41, 493500.
  • Saitoh, K., Miura, I., Takahashi, N. & Miura, A.B. (1998) Fluorescence in situ hybridisation of progenitor cells obtained by fluorescence activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood, 92, 28862892.
  • Schoch, C., Haferlach, T., Haase, D., Fonatsch, C., Loffler, H., Schlegelberger, B., Staib, P., Sauerland, M.C., Heinecke, A., Buchner, T., Hiddemann, W. & German AML Cooperative Study Group (2001) Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. British Journal of Haematology, 112, 118126.
  • Stasi, R., Del Poeta, G., Masi, M., Tribalto, M., Venditti, A., Papa, G., Nicoletti, B., Vernole, P., Tedeschi, B., Delaroche, I., Mingarelli, R. & Dallapiccola, B. (1993) Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukaemia. Cancer Genetics and Cytogenetics, 67, 2834.
  • Sumikuma, T., Shimazaki, C., Inaba, T., Ochiai, N., Okano, A., Hatsuse, M., Ashihara, E. & Nakagawa, M. (2002) CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation. British Journal of Haematology, 117, 238244.
  • Takahashi, T., Mizutani, M., Miwa, H., Katayama, N., Nishii, K., Shikami, M., Yamaguchi, M., Shiku, H., Kamada, N. & Kita, K. (1998) Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22). International Journal of Hematology, 67, 369378.
  • Vardiman, J.W., Harris, N.L. & Brunning, R.D. (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 100, 22922302.
  • Venditti, A., Del Poeta, G., Buccisano, F., Tamburini, A., Cox-Froncillo, M.C., Aronica, G., Bruno, A., Del Moro, B., Epiceno, A.M., Battaglia, A., Forte, L., Postorino, M., Cordero, V., Santinelli, S. & Amadori, S. (1998a) Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia, 12, 10561063.
  • Venditti, A., Del Poeta, G., Buccisano, F., Tamburini, A., Cox-Froncillo, M.C., Bruno, A., Del Moro, B., Epiceno, A.M., Masi, M., Amadori, S. & Stasi, R. (1998b) Biological features of acute myeloid leukemia in the elderly (letter). Blood, 92, 697699.
  • Wuchter, C., Ratei, R., Spahn, G., Schoch, C., Harbott, J., Schnittger, S., Haferlach, T., Creutzig, U., Sperling, C., Karawajew, L. & Ludwig, W.D. (2001) Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping. Haematologica, 86, 154161.
  • Zittoun, R., Suciu, S., De Witte, L., Resegotti, L., Liso, V., Willemze, R., Belhabri, A., Amadori, S., Giustolisi, R., Labor, B., Fioritoni, G., Rossi Ferrini, P., Leone, G., Jehn, U., Keating, S., Fazi, P., Dardenne, M., Solbu, G. & Mandelli, F. (1999) Comparison of three intercalating agents in induction and consolidation in acute myelogenous leukemia (AML) followed by autologous or allogeneic transplantation: preliminary results of the EORTC-GIMEMA AML-10 randomized trial (abstract). Blood, 94(Suppl. 1), 658.